![]() | |
Clinical data | |
---|---|
Other names | Cybutylone |
Legal status | |
Legal status | |
Identifiers | |
| |
PubChem CID | |
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C16H21NO3 |
Molar mass | 275.348 g·mol−1 |
3D model ( JSmol) | |
| |
|
N-Cyclohexylmethylone (cyputylone) is a substituted cathinone derivative with stimulant effects which has been sold as a designer drug. It was first identified in the United States in 2022. [2] [3]
![]() | |
Clinical data | |
---|---|
Other names | Cybutylone |
Legal status | |
Legal status | |
Identifiers | |
| |
PubChem CID | |
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C16H21NO3 |
Molar mass | 275.348 g·mol−1 |
3D model ( JSmol) | |
| |
|
N-Cyclohexylmethylone (cyputylone) is a substituted cathinone derivative with stimulant effects which has been sold as a designer drug. It was first identified in the United States in 2022. [2] [3]